Pub Date : 2026-02-20Epub Date: 2025-12-29DOI: 10.1016/j.ejogrb.2025.114924
James S. Morris , Smita Rajshekhar , Giulia Gremmo , Katie Keane , Saikat Banerjee
Deep endometriosis (DE) is established to cause chronic pelvic pain (CPP), lower urinary tract symptoms (LUTS) and altered bowel function. Although the aim of surgical excision is often to relieve CPP, evidence suggests it could also affect LUTS and bowel symptoms, especially where DE affects the bowel or urinary tract. We assessed the prevalence and improvements in CPP, LUTS and bowel symptoms in 130 patients preoperatively and 6 months following total excision of endometriosis using the British Society for Gynaecological Endoscopy (BSGE) Pelvic Pain Questionnaire. Pain symptoms and LUTS are graded 0–10 whilst bowel function is scored 0–4, each using Likert scales. Patients with urinary tract DE reported median bladder pain and bladder voiding dysfunction of 7/10 (95 % CI: 3–8) and 7/10 (95 % CI: 0–9), respectively. Improvements at follow-up did not reach statistical significance at the Šidák-adjusted significance threshold, although 80.0 % and 60.0 % of patients reported clinically important improvements to these respective symptoms. There were also no cases of de novo LUTS following excision of urinary tract DE. Patients with bowel DE reported CPP and menstrual dyschezia of 7/10 (95 % CI: 6–8) and 8/10 (95 % CI: 4–8), respectively. Although a significant proportion of patients with bowel DE reported clinically important improvements in bowel symptoms, the difference in symptomatic severity failed to reach statistical significance. Whilst excision of DE can produce clinically important improvements in LUTS and bowel symptoms in a large proportion of patients, there is also a considerable risk of occasioning de novo bowel symptoms.
{"title":"The impact of total laparoscopic excision of deep endometriosis (DE) on bladder and bowel dysfunction: a prospective longitudinal study","authors":"James S. Morris , Smita Rajshekhar , Giulia Gremmo , Katie Keane , Saikat Banerjee","doi":"10.1016/j.ejogrb.2025.114924","DOIUrl":"10.1016/j.ejogrb.2025.114924","url":null,"abstract":"<div><div>Deep endometriosis (DE) is established to cause chronic pelvic pain (CPP), lower urinary tract symptoms (LUTS) and altered bowel function. Although the aim of surgical excision is often to relieve CPP, evidence suggests it could also affect LUTS and bowel symptoms, especially where DE affects the bowel or urinary tract. We assessed the prevalence and improvements in CPP, LUTS and bowel symptoms in 130 patients preoperatively and 6 months following total excision of endometriosis using the British Society for Gynaecological Endoscopy (BSGE) Pelvic Pain Questionnaire. Pain symptoms and LUTS are graded 0–10 whilst bowel function is scored 0–4, each using Likert scales. Patients with urinary tract DE reported median bladder pain and bladder voiding dysfunction of 7/10 (95 % CI: 3–8) and 7/10 (95 % CI: 0–9), respectively. Improvements at follow-up did not reach statistical significance at the Šidák-adjusted significance threshold, although 80.0 % and 60.0 % of patients reported clinically important improvements to these respective symptoms. There were also no cases of <em>de novo</em> LUTS following excision of urinary tract DE. Patients with bowel DE reported CPP and menstrual dyschezia of 7/10 (95 % CI: 6–8) and 8/10 (95 % CI: 4–8), respectively. Although a significant proportion of patients with bowel DE reported clinically important improvements in bowel symptoms, the difference in symptomatic severity failed to reach statistical significance. Whilst excision of DE can produce clinically important improvements in LUTS and bowel symptoms in a large proportion of patients, there is also a considerable risk of occasioning <em>de novo</em> bowel symptoms.</div></div>","PeriodicalId":11975,"journal":{"name":"European journal of obstetrics, gynecology, and reproductive biology","volume":"318 ","pages":"Article 114924"},"PeriodicalIF":1.9,"publicationDate":"2026-02-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145881264","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-20Epub Date: 2026-01-05DOI: 10.1016/j.ejogrb.2026.114939
Giovanni Morganelli , Gabriella Maria Celora , Maria Chiara Bassi , Andrea Dall’Asta , Maurizio Di Serio , Vito Andrea Capozzi , Tullio Ghi , Stefania Fieni
Background
The potential preventive effect of mediolateral and lateral episiotomy on the risk of anal sphincter injury related to vacuum delivery in nullipara has been reported by different well-designed studies in the last years.
Objectives
The aim of this systematic review and meta-analysis is to summarize the available evidence on the protective effect of mediolateral or lateral episiotomy towards the occurrence of obstetric anal sphincter injury (OASI) in nulliparous women who were submitted to vacuum-assisted delivery.
Search strategy: PubMed, Embase, CINAHL, Cochrane Library and Scopus databases were retrospectively searched without any temporal restriction up to March 1st 2025.
Selection criteria: Randomized controlled trials, retrospective, prospective case-control or cohort studies investigating the incidence of perineal tears involving anal sphincter muscles and/or rectal mucosa after vacuum-assisted birth with and without mediolateral/lateral episiotomy in nulliparous women were included.
Data collection and analysis: Risk of bias assessment was conducted for each included study by applying ROB2 score for RCTs and ROBINS-I score for non-randomized studies. Data were extracted and analyzed with Review Manager 5.4.1, results were reported by means of pooled Odd-ratios (ORs) and presented as Forest plots.
Main results: 31 studies (3 RCTs and 28 non-randomized studies) were included. Cumulative sample size consisted in 608,359 nulliparous women who were submitted to vacuum-assisted delivery. Mediolateral/lateral episiotomy was found to halve the incidence of OASI (OR 0.56 [95 % CI 0.42–0.73]) with high between-study heterogeneity reported (I2 = 99 %). At sensitivity analysis, a significant reduction in OASI incidence in case of mediolateral/lateral episiotomy was confirmed (OR 0.58 [95 %CI 0.44–0.78]); this analysis was conducted on low/moderate risk of bias studies (1RCT e 5 non-randomized studies, 15,799 patients) and associated with low heterogeneity (I2 = 42 %).
Conclusions
This updated meta-analysis on the role of mediolateral/lateral episiotomy in nulliparous women submitted to vacuum assisted delivery confirms its protective role from OASI.
背景:在过去的几年里,不同的精心设计的研究已经报道了外阴中外侧切开术对肛门括约肌损伤风险的潜在预防作用。目的:本系统回顾和荟萃分析的目的是总结关于真空辅助分娩的未产妇女中外阴切开或外阴切开对产科肛门括约肌损伤(OASI)发生的保护作用的现有证据。检索策略:回顾性检索PubMed, Embase, CINAHL, Cochrane Library和Scopus数据库,无任何时间限制,截止到2025年3月1日。选择标准:包括随机对照试验、回顾性、前瞻性病例对照或队列研究,这些研究调查了无产妇女在有或没有外阴中外侧切开术的真空辅助分娩后涉及肛门括约肌和/或直肠粘膜的会阴撕裂的发生率。资料收集与分析:随机对照试验采用ROB2评分,非随机试验采用ROBINS-I评分,对每项纳入的研究进行偏倚风险评估。采用Review Manager 5.4.1软件对数据进行提取和分析,结果以混合奇比(or)报告,并以Forest样地表示。主要结果:纳入31项研究(3项rct和28项非随机研究)。累积样本量包括608359名接受真空辅助分娩的无产妇女。发现外阴内外侧切开术使OASI的发生率减少一半(OR 0.56 [95% CI 0.42-0.73]),研究间异质性较高(I2 = 99%)。在敏感性分析中,证实外阴中外侧切开术的OASI发生率显著降低(OR 0.58 [95% CI 0.44-0.78]);本分析是在低/中等偏倚风险研究(1RCT和5个非随机研究,15799例患者)中进行的,并且与低异质性相关(I2 = 42%)。结论:这一最新的荟萃分析证实了真空辅助分娩的无产妇女中外阴中外侧切开术的保护作用。
{"title":"Role of mediolateral or lateral episiotomy in preventing obstetric anal sphincter injury (OASI) in nulliparous women undergoing vacuum-assisted delivery: A systematic review and meta-analysis","authors":"Giovanni Morganelli , Gabriella Maria Celora , Maria Chiara Bassi , Andrea Dall’Asta , Maurizio Di Serio , Vito Andrea Capozzi , Tullio Ghi , Stefania Fieni","doi":"10.1016/j.ejogrb.2026.114939","DOIUrl":"10.1016/j.ejogrb.2026.114939","url":null,"abstract":"<div><h3>Background</h3><div>The potential preventive effect of mediolateral and lateral episiotomy on the risk of anal sphincter injury related to vacuum delivery in nullipara has been reported by different well-designed studies in the last years.</div></div><div><h3>Objectives</h3><div>The aim of this systematic review and <em>meta</em>-analysis is to summarize the available evidence on the protective effect of mediolateral or lateral episiotomy towards the occurrence of obstetric anal sphincter injury (OASI) in nulliparous women who were submitted to vacuum-assisted delivery.</div><div><em>Search strategy:</em> PubMed, Embase, CINAHL, Cochrane Library and Scopus databases were retrospectively searched without any temporal restriction up to March 1st 2025.</div><div><em>Selection criteria:</em> Randomized controlled trials, retrospective, prospective case-control or cohort studies investigating the incidence of perineal tears involving anal sphincter muscles and/or rectal mucosa after vacuum-assisted birth with and without mediolateral/lateral episiotomy in nulliparous women were included.</div><div><em>Data collection and analysis:</em> Risk of bias assessment was conducted for each included study by applying ROB2 score for RCTs and ROBINS-I score for non-randomized studies. Data were extracted and analyzed with Review Manager 5.4.1, results were reported by means of pooled Odd-ratios (ORs) and presented as Forest plots.</div><div><em>Main results:</em> 31 studies (3 RCTs and 28 non-randomized studies) were included. Cumulative sample size consisted in 608,359 nulliparous women who were submitted to vacuum-assisted delivery. Mediolateral/lateral episiotomy was found to halve the incidence of OASI (OR 0.56 [95 % CI 0.42–0.73]) with high between-study heterogeneity reported (I<sup>2</sup> = 99 %). At sensitivity analysis, a significant reduction in OASI incidence in case of mediolateral/lateral episiotomy was confirmed (OR 0.58 [95 %CI 0.44–0.78]); this analysis was conducted on low/moderate risk of bias studies (1RCT e 5 non-randomized studies, 15,799 patients) and associated with low heterogeneity (I<sup>2</sup> = 42 %).</div></div><div><h3>Conclusions</h3><div>This updated meta-analysis on the role of mediolateral/lateral episiotomy in nulliparous women submitted to vacuum assisted delivery confirms its protective role from OASI.</div></div>","PeriodicalId":11975,"journal":{"name":"European journal of obstetrics, gynecology, and reproductive biology","volume":"318 ","pages":"Article 114939"},"PeriodicalIF":1.9,"publicationDate":"2026-02-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145922007","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-20Epub Date: 2026-01-14DOI: 10.1016/j.ejogrb.2026.114966
Natasha Graham , Sanem Atakan , Jemma Johns , Jackie A. Ross
Objectives
To re-analyse and update a decision tree developed 20 years ago to counsel women regarding the likelihood of successful expectant management of tubal ectopic pregnancies. The original model was developed using the data from 179 cases.
Study design
A retrospective observational analysis spanning a 14-year period was undertaken at the early pregnancy unit of an inner-city teaching hospital. Data were collected for all women who had expectant management when first diagnosed with their tubal ectopic pregnancies. Initial serum human chorionic gonadotropin (hCG) and progesterone levels, gestational age, ectopic morphology and mean diameter of the ectopic were recorded. Data were analysed using decision tree analysis on SPSS (IBM).
Results
A total of 798/1968 (40.5%) women with tubal ectopic pregnancies had expectant management and a new decision tree was developed using data from these 798 cases. Expectant management was successful in 512/798. This was 64% of women embarking on expectant management and 26% of all women with tubal ectopic pregnancies. Initial serum hCG level remains the best predictor of success for expectant management. Combined with progesterone level and diameter measurement, the decision tree has been updated.
Conclusion
Biochemical and clinical markers can be used to help counsel women about the likelihood of successful expectant management in our early pregnancy unit using decision tree analysis.
{"title":"Expectant management of tubal ectopic pregnancy: Updated decision tree analysis for the prediction of successful outcomes","authors":"Natasha Graham , Sanem Atakan , Jemma Johns , Jackie A. Ross","doi":"10.1016/j.ejogrb.2026.114966","DOIUrl":"10.1016/j.ejogrb.2026.114966","url":null,"abstract":"<div><h3>Objectives</h3><div>To re-analyse and update a decision tree developed 20 years ago to counsel women regarding the likelihood of successful expectant management of tubal ectopic pregnancies. The original model was developed using the data from 179 cases.</div></div><div><h3>Study design</h3><div>A retrospective observational analysis spanning a 14-year period was undertaken at the early pregnancy unit of an inner-city teaching hospital. Data were collected for all women who had expectant management when first diagnosed with their tubal ectopic pregnancies. Initial serum human chorionic gonadotropin (hCG) and progesterone levels, gestational age, ectopic morphology and mean diameter of the ectopic were recorded. Data were analysed using decision tree analysis on SPSS (IBM).</div></div><div><h3>Results</h3><div>A total of 798/1968 (40.5%) women with tubal ectopic pregnancies had expectant management and a new decision tree was developed using data from these 798 cases. Expectant management was successful in 512/798. This was 64% of women embarking on expectant management and 26% of all women with tubal ectopic pregnancies. Initial serum hCG level remains the best predictor of success for expectant management. Combined with progesterone level and diameter measurement, the decision tree has been updated.</div></div><div><h3>Conclusion</h3><div>Biochemical and clinical markers can be used to help counsel women about the likelihood of successful expectant management in our early pregnancy unit using decision tree analysis.</div></div>","PeriodicalId":11975,"journal":{"name":"European journal of obstetrics, gynecology, and reproductive biology","volume":"318 ","pages":"Article 114966"},"PeriodicalIF":1.9,"publicationDate":"2026-02-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145973385","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-20Epub Date: 2025-12-19DOI: 10.1016/j.ejogrb.2025.114902
Luigi Della Corte , Mario Palumbo , Antonisia Pollio , Ilenia Nobile , Lara Cuomo , Giuseppe Bifulco
Introduction
Genitourinary syndrome of menopause (GSM) is a prevalent, progressive condition affecting more than half of postmenopausal women, often compromising vaginal and sexual health. While local estrogen therapy remains the mainstay of treatment, non-hormonal alternatives are increasingly required, particularly for women with contraindications to hormonal therapy.
Study design
To evaluate the efficacy and safety of a non-hormonal, Aloe-vera-based vaginal gel enriched with cellulose derivatives and plant extract and sugar complex in improving vaginal health and sexual function in postmenopausal women, as assessed by changes in vaginal pH, Vaginal Health Index (VHI), and Female Sexual Function Index (FSFI) over a six-month period. In this prospective observational study, 52 postmenopausal women were evaluated at baseline, 3 months, and 6 months. Vaginal pH was measured clinically, while the VHI and FSFI were assessed using instruments with established evidence of validity and reliability. Friedman and Wilcoxon tests were applied for within-subject comparisons, and linear mixed-effects models were fitted to evaluate the impact of time, age, and BMI.
Results
All parameters significantly improved over time (p < 0.0001). Mean vaginal pH decreased from 5.51 ± 0.39 at baseline to 4.75 ± 0.33 at 6 months, indicating partial restoration of vaginal acidity. VHI increased by + 5.89 ± 2.34 points, and FSFI improved by + 6.80 ± 3.15. At 6 months, 40.4 % of participants achieved FSFI scores ≥ 26.55. Linear mixed models confirmed time as a significant predictor, while age and BMI had no significant effect. No adverse events were reported.
Conclusions
Aloe-vera-based non-hormonal vaginal gel therapy significantly improved vaginal health and sexual function in postmenopausal women, independently of age and BMI. The formulation’s moisturizing, soothing, and protective properties likely underlie these benefits, offering a safe and effective non-hormonal option for the management of GSM.
{"title":"Non-hormonal vaginal gel improves vaginal and sexual health in menopausal women: results from a 6-month prospective study.","authors":"Luigi Della Corte , Mario Palumbo , Antonisia Pollio , Ilenia Nobile , Lara Cuomo , Giuseppe Bifulco","doi":"10.1016/j.ejogrb.2025.114902","DOIUrl":"10.1016/j.ejogrb.2025.114902","url":null,"abstract":"<div><h3>Introduction</h3><div>Genitourinary syndrome of menopause (GSM) is a prevalent, progressive condition affecting more than half of postmenopausal women, often compromising vaginal and sexual health. While local estrogen therapy remains the mainstay of treatment, non-hormonal alternatives are increasingly required, particularly for women with contraindications to hormonal therapy.</div></div><div><h3>Study design</h3><div>To evaluate the efficacy and safety of a non-hormonal, Aloe-vera-based vaginal gel enriched with cellulose derivatives and plant extract and sugar complex in improving vaginal health and sexual function in postmenopausal women, as assessed by changes in vaginal pH, Vaginal Health Index (VHI), and Female Sexual Function Index (FSFI) over a six-month period. In this prospective observational study, 52 postmenopausal women were evaluated at baseline, 3 months, and 6 months. Vaginal pH was measured clinically, while the VHI and FSFI were assessed using instruments with established evidence of validity and reliability. Friedman and Wilcoxon tests were applied for within-subject comparisons, and linear mixed-effects models were fitted to evaluate the impact of time, age, and BMI.</div></div><div><h3>Results</h3><div>All parameters significantly improved over time (p < 0.0001). Mean vaginal pH decreased from 5.51 ± 0.39 at baseline to 4.75 ± 0.33 at 6 months, indicating partial restoration of vaginal acidity. VHI increased by + 5.89 ± 2.34 points, and FSFI improved by + 6.80 ± 3.15. At 6 months, 40.4 % of participants achieved FSFI scores ≥ 26.55. Linear mixed models confirmed time as a significant predictor, while age and BMI had no significant effect. No adverse events were reported.</div></div><div><h3>Conclusions</h3><div>Aloe-vera-based non-hormonal vaginal gel therapy significantly improved vaginal health and sexual function in postmenopausal women, independently of age and BMI. The formulation’s moisturizing, soothing, and protective properties likely underlie these benefits, offering a safe and effective non-hormonal option for the management of GSM.</div></div>","PeriodicalId":11975,"journal":{"name":"European journal of obstetrics, gynecology, and reproductive biology","volume":"318 ","pages":"Article 114902"},"PeriodicalIF":1.9,"publicationDate":"2026-02-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145833471","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-20Epub Date: 2026-01-12DOI: 10.1016/j.ejogrb.2026.114959
Lucy F. Harvey , Fay F. Pon , Zaira N. Chavez Jimenez , Yadira L. Bribiesca Leon , Carolyn N. Rocha , Shinya Matsuzaki , Rachel S. Mandelbaum , Joseph G. Ouzounian , Koji Matsuo
{"title":"Assessment of maternal characteristics and outcomes associated with COVID-19-linked HELLP-like syndrome","authors":"Lucy F. Harvey , Fay F. Pon , Zaira N. Chavez Jimenez , Yadira L. Bribiesca Leon , Carolyn N. Rocha , Shinya Matsuzaki , Rachel S. Mandelbaum , Joseph G. Ouzounian , Koji Matsuo","doi":"10.1016/j.ejogrb.2026.114959","DOIUrl":"10.1016/j.ejogrb.2026.114959","url":null,"abstract":"","PeriodicalId":11975,"journal":{"name":"European journal of obstetrics, gynecology, and reproductive biology","volume":"318 ","pages":"Article 114959"},"PeriodicalIF":1.9,"publicationDate":"2026-02-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145973292","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-20Epub Date: 2026-01-02DOI: 10.1016/j.ejogrb.2026.114935
Mai Vuong Hung , Pham Thi Hai Ha , Nguyen Khac Han Hoan , Nguyen Thanh Luan
Background
While maternal age is established as a dominant reproductive risk factor, the mechanistic distinction between age-dependent meiotic errors and age-independent mitotic errors remains uncharacterized. These divergent pathways have profound implications for patient counseling and treatment stratification but are rarely differentiated clinically.
Objectives
To establish distinct etiological pathways underlying chromosomal abnormalities by quantifying the differential age-sensitivity of whole-chromosome aneuploidies (meiotic origin) versus mosaic abnormalities (mitotic origin), determining whether developmental timing serves as an age-independent biomarker of genomic competence, and enabling practitioners to provide pathway-specific counseling and treatment recommendations.
Search strategy
PubMed, Embase, and ClinicalTrials.gov were searched for relevant studies.
Selection criteria
Retrospective cohort of 490 IVF patients (2,472 embryos) stratified by maternal age (≤35, 35–40, ≥40 years) with complete extended culture and next-generation sequencing (NGS)-based preimplantation genetic testing for aneuploidy.
Data collection and analysis
Age-stratified analysis of developmental kinetics and comprehensive chromosomal classification. Multivariate logistic regression identified independent predictors of aneuploidy, adjusting for maternal age and day-5 blastocyst count.
Main results
Whole-chromosome aneuploidies demonstrated striking age-sensitivity (14.0 % to 36.5 %, 2.6-fold increase, p < 0.001), reflecting progressive cohesin complex degradation, spindle checkpoint decline, and mitochondrial bioenergetic insufficiency. Mosaicism remained age-independent (∼41 %, p = 0.383), arising from post-meiotic mitotic errors. Day-5 blastocyst formation declined 30 % with age (p = 0.0154), yet day-6 formation remained age-independent (p = 0.106), indicating developmental delay rather than failure. Day-5 blastocyst count independently protected against aneuploidy (OR 0.965, 95 % CI: 0.944–0.987, p = 0.002), persisting after multivariate adjustment.
Conclusions
Mechanistic differentiation between age-dependent meiotic and age-independent mitotic chromosomal abnormalities reveals fundamentally distinct etiological pathways with profound implications for clinical decision-making. In particular, day-5 blastocyst achievement emerges as an independent biomarker of oocyte quality, enabling precise within-age-group risk stratification regardless of chronological age. These findings translate developmental kinetics into quantitative clinical algorithms that substantially improve reproductive counseling accuracy and patient-specific prognostication beyond traditional age-based approaches.
{"title":"Developmental kinetics distinguish meiotic from mitotic chromosomal defects: Day-5 blastocyst achievement as age-independent predictor of euploid embryo yield","authors":"Mai Vuong Hung , Pham Thi Hai Ha , Nguyen Khac Han Hoan , Nguyen Thanh Luan","doi":"10.1016/j.ejogrb.2026.114935","DOIUrl":"10.1016/j.ejogrb.2026.114935","url":null,"abstract":"<div><h3>Background</h3><div>While maternal age is established as a dominant reproductive risk factor, the mechanistic distinction between age-dependent meiotic errors and age-independent mitotic errors remains uncharacterized. These divergent pathways have profound implications for patient counseling and treatment stratification but are rarely differentiated clinically.</div></div><div><h3>Objectives</h3><div>To establish distinct etiological pathways underlying chromosomal abnormalities by quantifying the differential age-sensitivity of whole-chromosome aneuploidies (meiotic origin) versus mosaic abnormalities (mitotic origin), determining whether developmental timing serves as an age-independent biomarker of genomic competence, and enabling practitioners to provide pathway-specific counseling and treatment recommendations.</div></div><div><h3>Search strategy</h3><div>PubMed, Embase, and ClinicalTrials.gov were searched for relevant studies.</div></div><div><h3>Selection criteria</h3><div>Retrospective cohort of 490 IVF patients (2,472 embryos) stratified by maternal age (≤35, 35–40, ≥40 years) with complete extended culture and next-generation sequencing (NGS)-based preimplantation genetic testing for aneuploidy.</div></div><div><h3>Data collection and analysis</h3><div>Age-stratified analysis of developmental kinetics and comprehensive chromosomal classification. Multivariate logistic regression identified independent predictors of aneuploidy, adjusting for maternal age and day-5 blastocyst count.</div></div><div><h3>Main results</h3><div>Whole-chromosome aneuploidies demonstrated striking age-sensitivity (14.0 % to 36.5 %, 2.6-fold increase, p < 0.001), reflecting progressive cohesin complex degradation, spindle checkpoint decline, and mitochondrial bioenergetic insufficiency. Mosaicism remained age-independent (∼41 %, p = 0.383), arising from post-meiotic mitotic errors. Day-5 blastocyst formation declined 30 % with age (p = 0.0154), yet day-6 formation remained age-independent (p = 0.106), indicating developmental delay rather than failure. Day-5 blastocyst count independently protected against aneuploidy (OR 0.965, 95 % CI: 0.944–0.987, p = 0.002), persisting after multivariate adjustment.</div></div><div><h3>Conclusions</h3><div>Mechanistic differentiation between age-dependent meiotic and age-independent mitotic chromosomal abnormalities reveals fundamentally distinct etiological pathways with profound implications for clinical decision-making. In particular, day-5 blastocyst achievement emerges as an independent biomarker of oocyte quality, enabling precise within-age-group risk stratification regardless of chronological age. These findings translate developmental kinetics into quantitative clinical algorithms that substantially improve reproductive counseling accuracy and patient-specific prognostication beyond traditional age-based approaches.</div></div>","PeriodicalId":11975,"journal":{"name":"European journal of obstetrics, gynecology, and reproductive biology","volume":"318 ","pages":"Article 114935"},"PeriodicalIF":1.9,"publicationDate":"2026-02-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145922008","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
HNF1B variant is a rare autosomal dominant disease that affects the embryonic development of the urogenital system, the mullerian development, the liver, the exocrine and endocrine pancreas functions responsible for MODY 5 diabetes. The objective of this study was to evaluate the ovarian reserve and the gyneco-obstetric profile of patients with an HNF1B anomaly.
Study design
This was a pilot study coordinated by the Reference Centre of Rare Gynecological Pathologies (RGP). It was conducted in 3 hospital sites after agreement of the Reference Centres of Rare Renal Diseases. The primary endpoint was the serum AMH concentration, the secondary endpoint was the gyneco-obstetric characteristics of the patients.
Results
26 of the 54 patients aged 29 ± 13 years agreed to participate. All are carriers of the HNF1 pathogenic variant with a deletion in 50% of cases. 38% of patients had an AMH level <25th percentile adjusted for age. No statistical significant association was observed with genetic, renal abnormality, or Mody diabetes. Their gynecological profile was comparable to general population. 42% had uterine malformation. Obstetric complications of threatened premature delivery, cholestasis of pregnancy were noted.
Conclusions
We have, for the first time, described the ovarian function and gyneco-obstetric profile of patients with an HNF1 variant. We highlighted the value of monitoring their ovarian reserve. Fertility preservation should be discussed on an individual basis. These data need to be confirmed by a larger study and a longitudinal follow up.
{"title":"Study of the ovarian function and gyneco-obstetrical profile of patients with an HNF1B abnormality","authors":"Audrey Cartault , Camille Paret , Charlotte Garczynski , Sabrina Da Costa , Zeina Chakhtoura , Perrine Ernoult , Dominique Chauveau , Stéphane Decramer , Stanislas Faguer , Magali Viaud , Céline Mercier , Vanessa Rousseau , Claire Thalamas , Nicolas Gatimel , Catherine Pienkowski","doi":"10.1016/j.ejogrb.2026.114961","DOIUrl":"10.1016/j.ejogrb.2026.114961","url":null,"abstract":"<div><h3>Objective</h3><div>HNF1B variant is a rare autosomal dominant disease that affects the embryonic development of the urogenital system, the mullerian development, the liver, the exocrine and endocrine pancreas functions responsible for MODY 5 diabetes. The objective of this study was to evaluate the ovarian reserve and the gyneco-obstetric profile of patients with an HNF1B anomaly.</div></div><div><h3>Study design</h3><div>This was a pilot study coordinated by the Reference Centre of Rare Gynecological Pathologies (RGP). It was conducted in 3 hospital sites after agreement of the Reference Centres of Rare Renal Diseases. The primary endpoint was the serum AMH concentration, the secondary endpoint was the gyneco-obstetric characteristics of the patients.</div></div><div><h3>Results</h3><div>26 of the 54 patients aged 29 ± 13 years agreed to participate. All are carriers of the HNF1 pathogenic variant with a deletion in 50% of cases. 38% of patients had an AMH level <25th percentile adjusted for age. No statistical significant association was observed with genetic, renal abnormality, or Mody diabetes. Their gynecological profile was comparable to general population. 42% had uterine malformation. Obstetric complications of threatened premature delivery, cholestasis of pregnancy were noted.</div></div><div><h3>Conclusions</h3><div>We have, for the first time, described the ovarian function and gyneco-obstetric profile of patients with an HNF1 variant. We highlighted the value of monitoring their ovarian reserve. Fertility preservation should be discussed on an individual basis. These data need to be confirmed by a larger study and a longitudinal follow up.</div></div>","PeriodicalId":11975,"journal":{"name":"European journal of obstetrics, gynecology, and reproductive biology","volume":"318 ","pages":"Article 114961"},"PeriodicalIF":1.9,"publicationDate":"2026-02-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146022741","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-20Epub Date: 2025-12-31DOI: 10.1016/j.ejogrb.2025.114931
Binze Chen , Teng Ma , Ying Liu , Mengting Wang , Tingting Yin , Yanxia Han
Purpose
To assess the accuracy of triglyceride-glucose index (TyG) in the diagnosis of gestational diabetes mellitus (GDM).
Methods
Embase, Cochrane Library, PubMed, and Web of Science were searched up to April 18, 2025 for English-language clinical studies using TyG for GDM prediction. The Quality Assessment of Diagnostic Accuracy Studies-2 (QUADAS-2) tool was utilized for quality assessment, and the final results were presented by RevMan5.3. The overall accuracy of TyG in GDM diagnosis was identified using Stata15.0 and Meta-DiSc1.4. We also performed subgroup analyses by the sample size, prevalence, cutoff, and trimester of pregnancy.
Results
Sixteen studies with 480,402 participants were included. The pooled sensitivity, specificity, positive likelihood ratio, negative likelihood ratio, and diagnostic odds ratio of TyG in GDM diagnosis were 0.63 (95 % CI 0.56–0.70), 0.64 (95 % CI 0.60–0.68), 1.80 (95 % CI 1.60–1.90), 0.57 (95 % CI 0.49–0.67), and 3.00 (95 % CI 2.00–4.00), respectively. The area under the summary receiver operating characteristic (SROC) curve of TyG was 0.68 (95 % CI 0.64–0.72). Subgroup analyses revealed that small sample sizes, high prevalence, cutoff < 8.5, and the second trimester corresponded to the high accuracy of TyG in GDM diagnosis.
Conclusion
TyG demonstrates moderate diagnostic accuracy for GDM, with an area under the SROC curve of 0.68. Considering the limitations of the available studies, more prospective studies are still required to clarify the diagnostic value of TyG in actual clinical practice and offer a stronger basis for clinical decision-making.
目的探讨甘油三酯-葡萄糖指数(TyG)在妊娠期糖尿病(GDM)诊断中的准确性。方法检索sembase、Cochrane Library、PubMed和Web of Science,检索截至2025年4月18日使用TyG预测GDM的英文临床研究。采用诊断准确性研究质量评估-2 (QUADAS-2)工具进行质量评估,最终结果由RevMan5.3给出。使用Stata15.0和Meta-DiSc1.4确定TyG在GDM诊断中的总体准确性。我们还根据样本量、患病率、截止时间和妊娠三个月进行了亚组分析。结果共纳入16项研究,480402名受试者。TyG在GDM诊断中的敏感性、特异性、阳性似然比、阴性似然比、诊断优势比分别为0.63 (95% CI 0.56 ~ 0.70)、0.64 (95% CI 0.60 ~ 0.68)、1.80 (95% CI 1.60 ~ 1.90)、0.57 (95% CI 0.49 ~ 0.67)、3.00 (95% CI 2.00 ~ 4.00)。TyG的综合受试者工作特征(SROC)曲线下面积为0.68 (95% CI 0.64 ~ 0.72)。亚组分析显示,样本量小、患病率高、临界值<; 8.5、妊娠中期与TyG在GDM诊断中的准确性较高相对应。结论tyg对GDM的诊断准确率中等,SROC曲线下面积为0.68。考虑到现有研究的局限性,仍需要更多的前瞻性研究来明确TyG在实际临床中的诊断价值,为临床决策提供更有力的依据。
{"title":"Value of triglyceride-glucose index in diagnosis of gestational diabetes mellitus: a systematic review and meta-analysis","authors":"Binze Chen , Teng Ma , Ying Liu , Mengting Wang , Tingting Yin , Yanxia Han","doi":"10.1016/j.ejogrb.2025.114931","DOIUrl":"10.1016/j.ejogrb.2025.114931","url":null,"abstract":"<div><h3>Purpose</h3><div>To assess the accuracy of triglyceride-glucose index (TyG) in the diagnosis of gestational diabetes mellitus (GDM).</div></div><div><h3>Methods</h3><div>Embase, Cochrane Library, PubMed, and Web of Science were searched up to April 18, 2025 for English-language clinical studies using TyG for GDM prediction. The Quality Assessment of Diagnostic Accuracy Studies-2 (QUADAS-2) tool was utilized for quality assessment, and the final results were presented by RevMan5.3. The overall accuracy of TyG in GDM diagnosis was identified using Stata15.0 and Meta-DiSc1.4. We also performed subgroup analyses by the sample size, prevalence, cutoff, and trimester of pregnancy.</div></div><div><h3>Results</h3><div>Sixteen studies with 480,402 participants were included. The pooled sensitivity, specificity, positive likelihood ratio, negative likelihood ratio, and diagnostic odds ratio of TyG in GDM diagnosis were 0.63 (95 % CI 0.56–0.70), 0.64 (95 % CI 0.60–0.68), 1.80 (95 % CI 1.60–1.90), 0.57 (95 % CI 0.49–0.67), and 3.00 (95 % CI 2.00–4.00), respectively. The area under the summary receiver operating characteristic (SROC) curve of TyG was 0.68 (95 % CI 0.64–0.72). Subgroup analyses revealed that small sample sizes, high prevalence, cutoff < 8.5, and the second trimester corresponded to the high accuracy of TyG in GDM diagnosis.</div></div><div><h3>Conclusion</h3><div>TyG demonstrates moderate diagnostic accuracy for GDM, with an area under the SROC curve of 0.68. Considering the limitations of the available studies, more prospective studies are still required to clarify the diagnostic value of TyG in actual clinical practice and offer a stronger basis for clinical decision-making.</div></div>","PeriodicalId":11975,"journal":{"name":"European journal of obstetrics, gynecology, and reproductive biology","volume":"318 ","pages":"Article 114931"},"PeriodicalIF":1.9,"publicationDate":"2026-02-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145881268","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-20Epub Date: 2025-12-22DOI: 10.1016/j.ejogrb.2025.114904
Ivo Vukasović , Držislav Kalafatić , Maja Banović , Vladimir Banović
Introduction
The perineal body (PB) is a pyramidal fibromuscular structure located in the anterior part of the perineum, between the rectum and the vagina. It serves as a crucial component of the pelvic floor support system, particularly at levels II and III. Current understanding of pelvic floor anatomy is largely derived from cadaveric dissection and magnetic resonance imaging (MRI). However, ultrasound offers a promising alternative due to its ability to provide dynamic, non-invasive assessment, along with broad availability and cost-effectiveness. Importantly, ultrasound has the potential to reveal new insights into the anatomy of the perineal body and its functional role in both the static and dynamic support of the female pelvic floor.
Material and methods
This review followed the PRISMA-ScR guidelines. A comprehensive literature search was conducted in MEDLINE, Scopus, Web of Science, and grey literature sources. Eligible studies included English-language publications involving ultrasound visualization or measurement of the PB in women. Data extraction and screening were conducted independently by two reviewers, with discrepancies resolved through consensus. Data extraction encompassed a comprehensive set of variables, including study number, study design, total sample size, subgroup sample sizes, ultrasound approach, probe type, parameters measured, imaging position, and main findings.
Results
A total of 22 studies were included in the scoping review, with publications ranging from 1997 to 2025. The majority of studies were observational, and sample sizes varied from 22 to 1340 (mean 154) participants. In most studies published before 2012, endoanal ultrasound (EAUS) was the most commonly used modality. With advances in transvaginal ultrasound technology and the introduction of transperineal ultrasound, detecting and measuring the perineal body has become more accessible and precise. The perineal body can now be measured in three dimensions—depth, height, and width—rather than relying solely on the traditional measurement of perineal body thickness.
Conclusions
In conclusion, the perineal body is an important anatomical structure that can be clearly visualized and measured using ultrasound; however, significant heterogeneity in imaging approaches, probe types, and anatomical definitions underscores the need for standardized methodologies to improve reproducibility and support future clinical application in the diagnosis and management of pelvic organ prolapse.
会阴体(PB)是位于会阴前部、直肠和阴道之间的锥体状纤维肌肉结构。它是骨盆底支撑系统的重要组成部分,特别是在II级和III级。目前对骨盆底解剖学的了解主要来自尸体解剖和磁共振成像(MRI)。然而,超声提供了一个很有前途的替代方案,因为它能够提供动态的、无创的评估,以及广泛的可用性和成本效益。重要的是,超声有可能揭示会阴体的解剖结构及其在女性骨盆底的静态和动态支撑中的功能作用。材料和方法本综述遵循PRISMA-ScR指南。在MEDLINE、Scopus、Web of Science和灰色文献资源中进行了全面的文献检索。符合条件的研究包括涉及超声可视化或女性PB测量的英文出版物。数据的提取和筛选由两位审稿人独立进行,差异通过共识解决。数据提取包括一组综合变量,包括研究数量、研究设计、总样本量、亚组样本量、超声入路、探头类型、测量参数、成像位置和主要发现。结果共纳入22项研究,发表文献范围从1997年到2025年。大多数研究是观察性的,样本量从22到1340(平均154)名参与者不等。在2012年之前发表的大多数研究中,肛管超声(EAUS)是最常用的方式。随着经阴道超声技术的进步和经会阴超声的引入,会阴体的检测和测量变得更加方便和精确。会阴体现在可以用三维测量——深度、高度和宽度——而不是仅仅依靠传统的会阴体厚度测量。结论会阴体是超声能清晰显示和测量的重要解剖结构;然而,成像方法、探头类型和解剖定义的显著异质性强调了标准化方法的必要性,以提高可重复性,并支持未来盆腔器官脱垂诊断和治疗的临床应用。
{"title":"Ultrasound assessment of the perineal body: A scoping review","authors":"Ivo Vukasović , Držislav Kalafatić , Maja Banović , Vladimir Banović","doi":"10.1016/j.ejogrb.2025.114904","DOIUrl":"10.1016/j.ejogrb.2025.114904","url":null,"abstract":"<div><h3>Introduction</h3><div>The perineal body (PB) is a pyramidal fibromuscular structure located in the anterior part of the perineum, between the rectum and the vagina. It serves as a crucial component of the pelvic floor support system, particularly at levels II and III. Current understanding of pelvic floor anatomy is largely derived from cadaveric dissection and magnetic resonance imaging (MRI). However, ultrasound offers a promising alternative due to its ability to provide dynamic, non-invasive assessment, along with broad availability and cost-effectiveness. Importantly, ultrasound has the potential to reveal new insights into the anatomy of the perineal body and its functional role in both the static and dynamic support of the female pelvic floor.</div></div><div><h3>Material and methods</h3><div>This review followed the PRISMA-ScR guidelines. A comprehensive literature search was conducted in MEDLINE, Scopus, Web of Science, and grey literature sources. Eligible studies included English-language publications involving ultrasound visualization or measurement of the PB in women. Data extraction and screening were conducted independently by two reviewers, with discrepancies resolved through consensus. Data extraction encompassed a comprehensive set of variables, including study number, study design, total sample size, subgroup sample sizes, ultrasound approach, probe type, parameters measured, imaging position, and main findings.</div></div><div><h3>Results</h3><div>A total of 22 studies were included in the scoping review, with publications ranging from 1997 to 2025. The majority of studies were observational, and sample sizes varied from 22 to 1340 (mean 154) participants. In most studies published before 2012, endoanal ultrasound (EAUS) was the most commonly used modality. With advances in transvaginal ultrasound technology and the introduction of transperineal ultrasound, detecting and measuring the perineal body has become more accessible and precise. The perineal body can now be measured in three dimensions—depth, height, and width—rather than relying solely on the traditional measurement of perineal body thickness.</div></div><div><h3>Conclusions</h3><div>In conclusion, the perineal body is an important anatomical structure that can be clearly visualized and measured using ultrasound; however, significant heterogeneity in imaging approaches, probe types, and anatomical definitions underscores the need for standardized methodologies to improve reproducibility and support future clinical application in the diagnosis and management of pelvic organ prolapse.</div></div>","PeriodicalId":11975,"journal":{"name":"European journal of obstetrics, gynecology, and reproductive biology","volume":"318 ","pages":"Article 114904"},"PeriodicalIF":1.9,"publicationDate":"2026-02-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145838153","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-20Epub Date: 2025-12-25DOI: 10.1016/j.ejogrb.2025.114920
Pragnesh Parmar , Gunvanti Rathod
{"title":"Confirming age before MTP in minors: reconciling POCSO mandates with adolescent reproductive rights","authors":"Pragnesh Parmar , Gunvanti Rathod","doi":"10.1016/j.ejogrb.2025.114920","DOIUrl":"10.1016/j.ejogrb.2025.114920","url":null,"abstract":"","PeriodicalId":11975,"journal":{"name":"European journal of obstetrics, gynecology, and reproductive biology","volume":"318 ","pages":"Article 114920"},"PeriodicalIF":1.9,"publicationDate":"2026-02-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145838112","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}